ThaiPR.NET https://www.thaipr.net/location/philadelphia-and-florence-italy Press Release Distribution Center of Thailand Thu, 30 Apr 2026 18:05:11 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination]]> https://www.thaipr.net/en/health_en/3219792 Wed, 03 Aug 2022 15:30:00 +0700 health_en https://www.thaipr.net/en/health_en/3219792 Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models Context to initiate Phase 1b/2 clinical trial in Q4 2022 Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, and The Menarini Group (“Menarini”) today […]

The post Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination appeared first on ThaiPR.NET.

]]>